Search
01/01/2024
Acute kidney injury (AKI): Spanish nomenclature also matters here
Bover, J, Romero-González, G, Chávez-Iñiguez, JS, Rizo-Topete, L, Graterol, F, Santandreu, AV, Sanchez-Baya, M, Díaz, JM, Ortiz, A, Poch, YE. Acute kidney injury (AKI): Spanish nomenclature also matters here. NEFROLOGIA. 2024; 44(1)DOI:https://doi.org/10.1016/j.nefroe.2024.02.009. PMID:. IF:2.600(Q2/4D).
01/01/2024
Neurodesarrollo a los 2 años en cardiopatía congénita: utilidad pronóstica de los marcadores de daño cerebral
Vega Puyal L., Llurba E., Ferrer Q., Dolader Codina P., Sánchez García O., Montoliu Ruiz A., Sanchez-de-Toledo J.. Neurodesarrollo a los 2 años en cardiopatía congénita: utilidad pronóstica de los marcadores de daño cerebral. ANALES DE PEDIATRIA. 2024; 100(1)DOI:10.1016/j.anpedi.2023.10.007. PMID:38185573. IF:2.100(Q2/4D).
01/01/2024
Exploring the Effectiveness of Self-Management Interventions in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Tsokani, S, Seitidis, G, Christogiannis, C, Kontouli, KM, Nikolakopoulos, S, Zevgiti, S, Orrego, C, Ballester, M, Suñol, R, Heijmans, M, Poortvliet, R, van der Gaag, M, Alonso-Coello, P, Canelo-Aybar, C, Beltran, J, González-Gonzalez, AI, de Graaf, G, Veroniki, AA, Mavridis, D. Exploring the Effectiveness of Self-Management Interventions in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Healthcare. 2024; 12(1)DOI:10.3390/healthcare12010027. PMID:38200933. IF:2.700(Q2/4D).
01/01/2024
Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trial
Perelló-Capó J., Estadella-Tarriel J., Gich-Saladich I., Bailón-Queiruga M., Llurba-Olivé E., Calaf-Alsina J.. Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trial. CONTRACEPTION. 2024; 133DOI:10.1016/j.contraception.2024.110367. PMID:38232939. IF:2.300(Q2/4D).